Wuxi Biologics (Cayman) (WXIBF) Stock Forecast & Price Target

Compare

153 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

WXIBF Analyst Ratings

Strong Buy

4 Buy

1 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Wuxi

Biologics (Cayman)

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

WXIBF Stock 12 Month Forecast

Average Price Target

$5.42

▲(29.98% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Wuxi Biologics (Cayman) in the last 3 months. The average price target is $5.42 with a high forecast of $6.43 and a low forecast of $4.31. The average price target represents a 29.98% change from the last price of $4.17.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","7":"$7","1.75":"$1.75","3.5":"$3.5","5.25":"$5.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6.425876,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$6.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.42,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.30533692,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.31</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.75,3.5,5.25,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.6,4.740451999999999,4.880903999999999,5.021356,5.161808,5.3022599999999995,5.442711999999999,5.583164,5.723616,5.864068,6.004519999999999,6.144971999999999,6.285423999999999,{"y":6.425876,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.6,4.663076923076923,4.726153846153846,4.789230769230769,4.852307692307692,4.915384615384615,4.978461538461538,5.041538461538462,5.104615384615385,5.167692307692308,5.230769230769231,5.293846153846154,5.356923076923077,{"y":5.42,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.6,4.577333609230769,4.554667218461538,4.532000827692308,4.509334436923076,4.486668046153846,4.464001655384616,4.441335264615384,4.418668873846154,4.3960024830769235,4.373336092307692,4.350669701538462,4.328003310769231,{"y":4.30533692,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.32,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.1,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.99,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.27,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.18,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.9,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.4,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.12,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$6.43

Average Price Target$5.42

Lowest Price Target$4.31

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jialin Zhang

Nomura

$4.8

Buy

15.14%

Upside

Reiterated

11/28/25

Laurence Tam

Morgan Stanley

$4.5→$5.78

Buy

38.69%

Upside

Reiterated

11/20/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ziyi Chen

Goldman Sachs

$3.77→$4.31

Hold

3.25%

Upside

Reiterated

10/17/25

Goldman Sachs Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$6.43

Buy

54.10%

Upside

Reiterated

10/08/25

Linda Shu

HSBC

$4.82→$5.78

Buy

38.69%

Upside

Reiterated

09/26/25

HSBC Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)HSBC analyst Linda Shu raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$45.00 (from HK$37.50) while maintaining a Buy rating.

Tony Ren

Macquarie

$5.14

Buy

23.28%

Upside

Reiterated

09/08/25

Macquarie Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)Macquarie analyst Tony Ren reiterated an Outperform rating and HK$40.00 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).

Chen Chen

UBS

$5.44→$6.03

Buy

44.54%

Upside

Reiterated

09/03/25

UBS Reaffirms Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)we revise up our Wuxi Apptec/Wuxi Bio long-term operation estimates with lower WACC, raising our DCF-based price targets from HK$119.80 /HK$42.30 to HK$136.10/HK$46.90. ... We maintain our Buy ratings.

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

$6.19

Buy

48.49%

Upside

Reiterated

08/31/25

Nico Chen

DBS

$3.01→$4.63

Hold

10.95%

Upside

Reiterated

08/26/25

DBS Sticks to Their Hold Rating for Wuxi Biologics (Cayman) (WXIBF)

Unknown Analyst

CCB Intl.

Not Ranked

CCB Intl.

$5.01

Buy

20.20%

Upside

Reiterated

08/26/25

Michael Luo CFA

CLSA

$4.47→$5.47

Buy

31.29%

Upside

Reiterated

08/25/25

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

$6.19

Buy

48.49%

Upside

Reiterated

08/23/25

Yang Huang

J.P. Morgan

$4.63→$4.76

Buy

14.03%

Upside

Reiterated

08/21/25

J.P. Morgan Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)JPMorgan analyst Yang Huang raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$37.00 (from HK$36.00) while maintaining a Overweight rating.

Jill Wu

CMB International Securities

$4.58

Buy

9.72%

Upside

Reiterated

08/21/25

John Yung

Citi

$4.5→$5.14

Buy

23.28%

Upside

Reiterated

08/21/25

Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Citi

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jialin Zhang

Nomura

$4.8

Buy

15.14%

Upside

Reiterated

11/28/25

Laurence Tam

Morgan Stanley

$4.5→$5.78

Buy

38.69%

Upside

Reiterated

11/20/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ziyi Chen

Goldman Sachs

$3.77→$4.31

Hold

3.25%

Upside

Reiterated

10/17/25

Goldman Sachs Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$6.43

Buy

54.10%

Upside

Reiterated

10/08/25

Linda Shu

HSBC

$4.82→$5.78

Buy

38.69%

Upside

Reiterated

09/26/25

Tony Ren

Macquarie

$5.14

Buy

23.28%

Upside

Reiterated

09/08/25

Macquarie Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)Macquarie analyst Tony Ren reiterated an Outperform rating and HK$40.00 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).

Chen Chen

UBS

$5.44→$6.03

Buy

44.54%

Upside

Reiterated

09/03/25

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

$6.19

Buy

48.49%

Upside

Reiterated

08/31/25

Nico Chen

DBS

$3.01→$4.63

Hold

10.95%

Upside

Reiterated

08/26/25

DBS Sticks to Their Hold Rating for Wuxi Biologics (Cayman) (WXIBF)

Unknown Analyst

CCB Intl.

Not Ranked

CCB Intl.

$5.01

Buy

20.20%

Upside

Reiterated

08/26/25

Michael Luo CFA

CLSA

$4.47→$5.47

Buy

31.29%

Upside

Reiterated

08/25/25

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

$6.19

Buy

48.49%

Upside

Reiterated

08/23/25

Yang Huang

J.P. Morgan

$4.63→$4.76

Buy

14.03%

Upside

Reiterated

08/21/25

Jill Wu

CMB International Securities

$4.58

Buy

9.72%

Upside

Reiterated

08/21/25

John Yung

Citi

$4.5→$5.14

Buy

23.28%

Upside

Reiterated

08/21/25

Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Citi

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wuxi Biologics (Cayman)

1 Month

xxx

Success Rate

3/3 ratings generated profit

Average Return

+8.57%

reiterated a xxx

rating 29 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +8.57% per trade.

3 Months

xxx

Success Rate

6/8 ratings generated profit

Average Return

+13.69%

reiterated a xxx

rating 21 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +13.69% per trade.

1 Year

Yang HuangJ.P. Morgan

Success Rate

4/4 ratings generated profit

Average Return

+42.15%

reiterated a buy rating 4 months ago

Copying Yang Huang's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +42.15% per trade.

2 Years

xxx

Success Rate

4/4 ratings generated profit

Average Return

+42.15%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +42.15% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WXIBF Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, WXIBF has received 7 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. WXIBF average Analyst price target in the past 3 months is 5.42.

Each month's total comprises the sum of three months' worth of ratings.

WXIBF Financial Forecast

WXIBF Earnings Forecast

Next quarter’s earnings estimate for WXIBF is $0.08 with a range of $0.08 to $0.08. The previous quarter’s EPS was $0.08. WXIBF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year WXIBF has Performed in-line its overall industry.

WXIBF Sales Forecast

Next quarter’s sales forecast for WXIBF is $1.65B with a range of $1.65B to $1.65B. The previous quarter’s sales results were $1.37B. WXIBF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year WXIBF has Performed in-line its overall industry.

WXIBF Stock Forecast FAQ

What is WXIBF’s average 12-month price target, according to analysts?

Based on analyst ratings, Wuxi Biologics (Cayman) Inc.’s 12-month average price target is 5.42.

What is WXIBF’s upside potential, based on the analysts’ average price target?

Wuxi Biologics (Cayman) Inc. has 29.98% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is WXIBF a Buy, Sell or Hold?

Wuxi Biologics (Cayman) Inc. has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.

What is Wuxi Biologics (Cayman) Inc.’s price target?

The average price target for Wuxi Biologics (Cayman) Inc. is 5.42. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $6.43 ,the lowest forecast is $4.31. The average price target represents 29.98% Increase from the current price of $4.17.

What do analysts say about Wuxi Biologics (Cayman) Inc.?

Wuxi Biologics (Cayman) Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of WXIBF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Wuxi Biologics (Cayman) (WXIBF) Stock Forecast & Price Target

WXIBF Analyst Ratings

WXIBF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Wuxi Biologics (Cayman)

WXIBF Analyst Recommendation Trends

WXIBF Financial Forecast

WXIBF Earnings Forecast

WXIBF Sales Forecast

WXIBF Stock Forecast FAQ

Detailed List of Analyst Forecasts